(Q87461308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

review article

4 references

13 July 2022

22 August 2022

22 October 2022

Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

People's Republic of China

10 April 2020

main subject

0 references

1

Robert L. Kruse

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

publication date

31 January 2020

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

13 July 2022

22 August 2022

22 October 2022

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

13 July 2022

22 August 2022

22 October 2022

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

page(s)

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

10 April 2020

copyright license

3 references

13 July 2022

22 August 2022

CD4 immunoadhesins in anti-HIV therapy: new developments

22 October 2022

cites work

1 reference

12 December 2020

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

1 reference

12 December 2020

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

1 reference

12 December 2020

Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study Team

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Clinical course and management of SARS in health care workers in Toronto: a case series.

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

1 reference

12 December 2020

SARS--beginning to understand a new virus

1 reference

12 December 2020

Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto

1 reference

12 December 2020

Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.

1 reference

12 December 2020

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

1 reference

12 December 2020

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.

1 reference

12 December 2020

Angiotensin-converting enzyme 2 protects from severe acute lung failure

1 reference

12 December 2020

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

1 reference

12 December 2020

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

12 December 2020

Antiviral therapy targeting viral polymerase

1 reference

12 December 2020

Pathology and pathogenesis of severe acute respiratory syndrome

1 reference

12 December 2020

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates

1 reference

12 December 2020

Viral protease inhibitors

1 reference

12 December 2020

Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.

1 reference

12 December 2020

High prevalence of human anti-mouse antibodies in the serum of colorectal cancer patients

1 reference

12 December 2020

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

12 December 2020

Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing

1 reference

12 December 2020

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

1 reference

12 December 2020

Viral infection modulation and neutralization by camelid nanobodies

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects

1 reference

12 December 2020

Increasing serum soluble angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in acute decompensated heart failure.

1 reference

12 December 2020

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines

1 reference

12 December 2020

Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus

1 reference

12 December 2020

Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.

1 reference

12 December 2020

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Biopharma CRO industry in China: landscape and opportunities

1 reference

12 December 2020

AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

1 reference

12 December 2020

Small molecules with antiviral activity against the Ebola virus

1 reference

12 December 2020

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

1 reference

12 December 2020

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

1 reference

12 December 2020

The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases

1 reference

12 December 2020

Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak

1 reference

12 December 2020

Convalescent plasma: new evidence for an old therapeutic tool?

1 reference

12 December 2020

Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus

1 reference

12 December 2020

Clinical Management of Ebola Virus Disease in the United States and Europe

1 reference

12 December 2020

Harnessing Fc receptor biology in the design of therapeutic antibodies

1 reference

12 December 2020

Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems

1 reference

12 December 2020

Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial

1 reference

12 December 2020

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates

1 reference

12 December 2020

Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA

1 reference

12 December 2020

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

1 reference

12 December 2020

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

1 reference

12 December 2020

Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers

1 reference

12 December 2020

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

1 reference

12 December 2020

IgG Fc engineering to modulate antibody effector functions

1 reference

12 December 2020

Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook

1 reference

12 December 2020

Passive immunotherapy of viral infections: 'super-antibodies' enter the fray

1 reference

12 December 2020

A review on current status of antiviral siRNA.

1 reference

12 December 2020

Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation

1 reference

12 December 2020

Generation of therapeutic antisera for emerging viral infections

1 reference

12 December 2020

Isolation of HCV Neutralizing Antibodies by Yeast Display

1 reference

12 December 2020

Repurposing host-based therapeutics to control coronavirus and influenza virus

1 reference

12 December 2020

Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library

1 reference

12 December 2020

AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges

1 reference

12 December 2020

Structural insights into coronavirus entry

1 reference

12 December 2020

Breaking the Convention: Sialoglycan Variants, Coreceptors, and Alternative Receptors for Influenza A Virus Entry

1 reference

12 December 2020

A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups

1 reference

12 December 2020

Molecular mechanism for antibody-dependent enhancement of coronavirus entry

1 reference

12 December 2020

Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development

1 reference

12 December 2020

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

1 reference

12 December 2020

Preparedness and proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China

1 reference

12 December 2020

A Novel Coronavirus from Patients with Pneumonia in China, 2019

1 reference

12 December 2020

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

1 reference

12 December 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

12 December 2020

10.12688/F1000RESEARCH.22211.1

Identifiers

DOI

0 references

10.12688/F1000RESEARCH.22211.2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

0 references

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32117569%20AND%20SRC:MED&resulttype=core&format=json